SEARCH

Search Details

IMAFUKU Hitomi
University Hospital / Center for Perinatal Care
Associate Professor

Researcher basic information

■ Research Areas
  • Life sciences / Obstetrics and gynecology

Research activity information

■ Paper
  • Manabu Ogoyama, Junichi Hasegawa, Kohei Kitada, Akitaka Kuramoto, Kohei Ogawa, Tatsuya Arakaki, Eri Soga, Masatoshi Saito, Takahiro Seyama, Shota Saji, Chiho Fuseya, Saki Kunimoto, Hitomi Imafuku, Hirotada Suzuki, Daisuke Tachibana, Hironori Takahashi
    Elsevier BV, Sep. 2025, European Journal of Obstetrics & Gynecology and Reproductive Biology, 313, 114591 - 114591
    Scientific journal

  • Naohisa Masuko, Kenji Tanimura, Koki Moriuchi, Tomomi Kita, Kenta Obata, Sonoko Suda, Hitomi Imafuku, Masashi Deguchi, Keiji Kurata, Kimikazu Yakushijin, Keiji Kono, Takuya Kawakatsu, Yoshito Terai
    Elsevier BV, Jul. 2025, Taiwanese Journal of Obstetrics and Gynecology, 64(4) (4), 703 - 706
    Scientific journal

  • Masayuki Tanaka, Hitomi Imafuku, Iroha Kubota, Keitaro Yamanaka, Sonoko Suda, Naohisa Masuko, Akiko Uchida, Hidenori Fukuoka, Masanori Teshima, Kazumichi Fujioka, Masashi Deguchi, Kenji Tanimura, Yoshito Terai
    Primary hyperparathyroidism (PHPT) during pregnancy is rare, causing severe pregnancy complications. We report a pregnant woman with PHPT and a pregnancy complication history who underwent a single-gland parathyroidectomy during the second trimester and delivered at term. A 28-year-old pregnant woman, gravida 3, para 2, was referred to our hospital at 9 gestational weeks (GWs) because of previous intrauterine fetal death, preterm birth, and fetal growth restriction. She was diagnosed with PHPT during her second pregnancy, and her baby experienced neonatal hypocalcemia. However, she received no PHPT treatment afterward. Laboratory tests and neck ultrasound revealed hyperparathyroidism and an enlarged right superior parathyroid gland. She underwent a right superior parathyroidectomy at 24 GWs. She delivered a 2,136 g (-1.74 SD) healthy female infant at 37 GWs, and her baby demonstrated no neonatal hypocalcemia. Parathyroidectomy, even during pregnancy, should be considered among pregnant women with PHPT having a pregnancy or neonatal complication history.
    May 2025, The Kobe journal of medical sciences, 71(1) (1), E41-E45, English, Domestic magazine
    Scientific journal

  • Yumi Kitahiro, Mari Hashimoto, Yukako Sonda, Miki Yagi, Kotaro Itohara, Takumi Kido, Kazumichi Fujioka, Hitomi Imafuku, Tomohiro Omura, Ikuko Yano
    Abstract Background Torasemide, a loop diuretic, is rarely used for pregnant women because of the risk of reduced placental blood flow resulting from decreased circulating plasma volume. We experienced a case of a newborn with metabolic alkalosis and mild polyuria. The mother was suspected of self-medicating as we detected torasemide in the neonatal serum by LC-MS/MS method. Case presentation A Japanese pregnant woman in her 20s with mental illness, symptoms of panic and eating disorders, and a history of overdosing on over-the-counter medications, was referred to our hospital for birth control. She presented with vomiting following bulimia nervosa and hypokalemia. Her baby was delivered vaginally at 36 weeks and 4 days of gestation. The baby’s blood gas analysis on day 0 revealed metabolic alkalosis (pH > 7.42, HCO3 - > 28 mmHg). Up to 16 h after birth, mild polyuria and a urine output of 3.3 mL/kg/h were observed without the administration of diuretics. We suspected diuretic intake by the mother before delivery, because she had a history of taking torasemide before being referred to the hospital. As expected, torasemide was detected in the baby’s serum. The serum concentration on the first day after delivery (4.80 ng/mL) gradually decreased to 0.45 ng/mL on day 5, whereas torasemide was not detected in the maternal serum. Neonatal metabolic alkalosis improved by day 3 following birth. Conclusions This case suggests close counseling and monitoring of pregnant women before childbirth regarding their past and present use of drugs, particularly in those with mental illness.
    Springer Science and Business Media LLC, Apr. 2025, Journal of Pharmaceutical Health Care and Sciences, 11(1) (1)
    Scientific journal

  • Toru Konishi, Yumi Kitahiro, Naoko Fujiwara, Kazuhiro Yamamoto, Mari Hashimoto, Takahiro Ito, Kotaro Itohara, Kazumichi Fujioka, Hitomi Imafuku, Ikuo Otsuka, Tomohiro Omura, Ikuko Yano
    BACKGROUND: Brexpiprazole is a second-generation antipsychotic approved in Japan in 2018; however, information on placental passage and breast milk transfer remains limited. In this report, the patient, a 30-year-old pregnant woman with schizophrenia, was medicated with brexpiprazole, risperidone, and quetiapine. METHODS: The study used high-performance liquid chromatography-tandem mass spectrometry to determine the concentrations of brexpiprazole, quetiapine, risperidone, and its active metabolite (paliperidone) in maternal and neonatal plasma, cord venous plasma, and breast milk. Maternal plasma samples were obtained approximately 2 and 8 hours after the last administration of antipsychotics on the day of delivery and at the estimated drugs' trough time on days 1, 3, and 5 after delivery. RESULTS: The maternal plasma concentrations of brexpiprazole, quetiapine, and paliperidone increased by approximately 3.5-fold on the fifth day compared with those on the day of delivery, whereas the risperidone concentration remained almost constant. Moreover, the neonatal plasma concentrations of the 4 drugs immediately after birth were indistinguishable from the umbilical cord concentrations and gradually decreased, except for risperidone. Relative infant doses of these compounds were below 1.1%. CONCLUSIONS: Pregnancy status notably alters the pharmacokinetic properties of antipsychotics. Therefore, close and careful monitoring of clinical symptoms should be considered during pregnancy and after delivery. Although brexpiprazole is transferred to neonates through the placenta, breastfeeding is still possible because the relative infant dose value of this drug was much less than 10%.
    Oct. 2024, Therapeutic drug monitoring, 46(5) (5), 687 - 691, English, International magazine
    Scientific journal

  • Masako Tomimoto, Kenji Tanimura, Naohisa Masuko, Akiko Uchida, Hitomi Imafuku, Masashi Deguchi, Akane Yamamoto, Yushi Hirota, Wataru Ogawa, Yoshito Terai
    ABSTRACT Aims/Introduction This study aimed to evaluate the problems in screening for gestational diabetes mellitus (GDM) by casual blood glucose (CBG) measurements at 24–28 gestational weeks. Materials and Methods Overall, 763 pregnant women who underwent the 50‐g glucose challenge test (GCT) at 24–28 gestational weeks were enrolled. The preload blood glucose (0‐h BG) level of 50‐g GCT was considered as CBG. Results A total of 240 women with BG levels at 1‐h after loading (1‐h BG) on 50‐g GCT ≥140 mg/dL underwent the 75‐g oral glucose tolerance test, and 98 (40.8%) were diagnosed with GDM. Of the 99 women with GDM, 71 (71.7%) had 0‐h BG on 50‐g GCT <100 mg/dL. Conclusions This study, where pregnant women underwent both CBG and 50‐g GCT simultaneously, showed that when CBG at 24–28 gestational weeks ≥100 mg/dL alone was used for screening GDM, many pregnant women with GDM were overlooked.
    Wiley, Sep. 2024, Journal of Diabetes Investigation, 15(12) (12), 1797 - 1802
    Scientific journal

  • Yoshinori Ito, Ichiro Morioka, Naoto Takahashi, Kazumichi Fujioka, Kiyonori Miura, Hiroyuki Moriuchi, Noriko Morimoto, Tetsushi Yoshikawa, Mariko Ashina, Shinya Abe, Hitomi Imafuku, Akiko Uchida, Aya Okahashi, Satsuki Kakiuchi, Yu Kakimoto, Soichiro Kawata, Yoshiki Kawamura, Takumi Kido, Hiroyuki Kidokoro, Kei Kozawa, Tomohiro Samejima, Takako Suzuki, Kenji Tanimura, Chiharu Tomonaga, Yuka Torii, Megumi Nakanishi, Nobuhiko Nagano, Takeshi Nagamatsu, Hajime Narita, Koji Nishimura, Norie Nonobe, Yuri Hasegawa, Koichiro Hara, Midori Hijikata, Takuya Fukuda, Yusuke Funato, Nobuko Mimura, Nobuko Yamamoto, Ai Yoshitomi, Yasumasa Kakei, Tomoyuki Kodama, Akira Oka
    Congenital cytomegalovirus (cCMV) infection is the most common congenital infection in developed countries. Although a standard therapy has not yet been established, evidence for the management of cCMV infection has been accumulating. The first edition of the “Clinical Practice Guidelines for the Management of Congenital Cytomegalovirus Infection” was published in Japan in 2023. This summary outlines the clinical questions (CQs) in the guidelines, with reference to the Japanese Medical Information Distribution Service Manual. Overall, 20 CQs with statements regarding prenatal risk assessment, prevention and management at diagnosis (CQs 1-1–1-3), diagnosis (CQs 2-1–2-6), treatment (CQs 3-1–3-7) and follow-up requirements (CQs 4-1–4-4) have been discussed. For each statement, the levels of recommendation, evidence and consensus rates were determined. These guidelines will assist in the management of patients with cCMV infection.
    Ovid Technologies (Wolters Kluwer Health), Jul. 2024, Pediatric Infectious Disease Journal, 43(11) (11), e390 - e396
    Scientific journal

  • Naohisa Masuko, Kenji Tanimura, Masayuki Tanaka, Akiko Uchida, Ryosuke Takahashi, Hitomi Imafuku, Masashi Deguchi, Yoshito Terai
    Hemolysis, elevated liver enzyme levels, and low platelet count (HELLP) syndrome is one of the most severe complications of hypertensive disorders of pregnancy. HELLP syndrome occurring before 22 gestational weeks (GWs) is extremely rare, and patients prevalently exhibit underlying maternal diseases or fetal abnormalities. Here, we report the case of a pregnant woman who had HELLP syndrome at 20 GWs without any obvious underlying maternal diseases or fetal abnormalities. A 38-year-old pregnant woman was referred to Kobe University Hospital from another hospital at 19 + 5/7 GWs for hypertension, proteinuria, generalized edema, and fetal growth restriction. She was diagnosed with partial HELLP syndrome according to the Mississippi classification at 20 + 2/7 GWs. The patient was managed following the Mississippi protocol, including intravenous dexamethasone, magnesium sulfate, and antihypertensive drugs. She received intensive blood pressure and laboratory data monitoring using an arterial line and additional treatments, including platelet transfusion, intravenous haptoglobin infusion, and human atrial natriuretic peptide. The pregnancy ended in an induced delivery at 20 + 3/7 GWs, and she was discharged without complications 10 days postnatal. We performed laboratory tests for diagnosing underlying diseases but identified no obvious underlying diseases. This report indicates that early and intensive treatment of patients with HELLP syndrome occurring before 22 GWs according to the Mississippi protocol may enable clinicians to complete pregnancy termination without maternal complications and provide useful information to clinical practitioners in perinatal medicine.
    Apr. 2024, The Kobe journal of medical sciences, 70(1) (1), E22-E25, English, Domestic magazine
    Scientific journal

  • Hitomi Imafuku, Kenji Tanimura, Naohisa Masuko, Masako Tomimoto, Yutoku Shi, Akiko Uchida, Masashi Deguchi, Kazumichi Fujioka, Akane Yamamoto, Kei Yoshino, Yushi Hirota, Wataru Ogawa, Yoshito Terai
    Abstract Aims/Introduction To evaluate the efficacy of sensor‐augmented pump (SAP) for improving obstetric and neonatal outcomes among pregnant women with type 1 diabetes mellitus by comparing it with continuous subcutaneous insulin infusion plus self‐monitoring of blood glucose (continuous subcutaneous insulin infusion [CSII]/SMBG). Materials and Methods This retrospective cohort study included 40 cases of pregnancy complicated by type 1 diabetes mellitus treated with SAP (SAP group), and 29 cases of pregnancy complicated by type 1 diabetes mellitus treated with CSII/SMBG (CSII/SMBG group). The obstetric and neonatal outcomes were compared between the two groups. Results The median of the glycoalbumin levels in the first (18.8% vs 20.9%; P < 0.05) and second (15.4% vs 18.0%; P < 0.05) trimesters, the hemoglobin A1c levels in the peripartum period (6.1% vs 6.5%; P < 0.05) and the standard deviation score of birthweights (0.36 vs 1.52; P < 0.05) were significantly lower in the SAP group than in the CSII/SMBG group. The incidence rate of large for gestational age newborns was significantly lower in the SAP group than in the CSII/SMBG group (27.5% vs 65.5%; P < 0.05). No significant differences in the incidence rates of hypertensive disorders of pregnancy, small for gestational age, respiratory distress syndrome, neonatal hypoglycemia, hypervolemia and hyperbilirubinemia were observed between the groups. Conclusion The present study showed that SAP therapy is more effective in preventing large for gestational age newborns in pregnant women with type 1 diabetes mellitus than CSII/SMBG.
    Wiley, Sep. 2023, Journal of Diabetes Investigation, 14(12) (12), 1383 - 1390
    Scientific journal

  • 谷村 憲司, 内田 明子, 今福 仁美, 平久 進也, 藤岡 一路, 森岡 一朗, 峰松 俊夫, 山田 秀人
    日本産婦人科・新生児血液学会, Mar. 2023, 日本産婦人科・新生児血液学会誌, 32(2) (2), 27 - 33, Japanese

  • Walaa Y B Mahdy, Kazuhiro Yamamoto, Takahiro Ito, Naoko Fujiwara, Kazumichi Fujioka, Tadasu Horai, Ikuo Otsuka, Hitomi Imafuku, Tomohiro Omura, Kazumoto Iijima, Ikuko Yano
    This study aimed to determine the effects of pregnancy and ontogeny on risperidone and paliperidone pharmacokinetics by assessing their serum concentrations in two subjects and constructing a customized physiologically-based pharmacokinetic (PBPK) model. Risperidone and paliperidone serum concentrations were determined in a pregnant woman and her newborn. PBPK models for risperidone and paliperidone in adults, pediatric, and pregnant populations were developed and verified using the Simcyp simulator. These models were then applied to our two subjects, generating their "virtual twins." Effects of pregnancy on both drugs were examined using models with fixed pharmacokinetic parameters. In the neonatal PBPK simulation, 10 different models for estimating the renal function of neonates were evaluated. Risperidone was not detected in the serum of both pregnant woman and her newborn. Maternal and neonatal serum paliperidone concentrations were between 2.05-3.80 and 0.82-1.03 ng/ml, respectively. Developed PBPK models accurately predicted paliperidone's pharmacokinetics, as shown by minimal bias and acceptable precision across populations. The individualized maternal model predicted all observed paliperidone concentrations within the 90% prediction interval. Fixed-parameter simulations showed that CYP2D6 activity largely affects risperidone and paliperidone pharmacokinetics during pregnancy. The Flanders metadata equation showed the lowest absolute bias (mean error: 22.3% ± 6.0%) and the greatest precision (root mean square error: 23.8%) in predicting paliperidone plasma concentration in the neonatal population. Our constructed PBPK model can predict risperidone and paliperidone pharmacokinetics in pregnant and neonatal populations, which could help with precision dosing using the PBPK model-informed approach in special populations.
    Jan. 2023, Clinical and translational science, English, International magazine
    Scientific journal

  • Kenji Tanimura, Akiko Uchida, Mizuki Uenaka, Hitomi Imafuku, Shinya Tairaku, Hiromi Hashimura, Yoshiko Ueno, Takumi Kido, Kazumichi Fujioka
    Congenital cytomegalovirus infection (cCMV) can cause fetal growth restriction (FGR) and severe sequelae in affected infants. Clinicians generally suspect cCMV based on multiple ultrasound (US) findings associated with cCMV. However, no studies have assessed the diagnostic accuracy of fetal US for cCMV-associated abnormalities in FGR. Eight FGR and 10 non-FGR fetuses prenatally diagnosed with cCMV were examined by undergoing periodic detailed US examinations, as well as postnatal physical and imaging examinations. The diagnostic accuracy of prenatal US for cCMV-associated abnormalities was compared between FGR and non-FGR fetuses with cCMV. The diagnostic sensitivity rates of fetal US for cCMV-related abnormalities in FGR vs. non-FGR fetuses were as follows: ventriculomegaly, 66.7% vs. 88.9%; intracranial calcification, 20.0% vs. 20.0%; cysts and pseudocysts in the brain, 0% vs. 0%; ascites, 100.0% vs. 100.0%; hepatomegaly, 40.0% vs. 100.0%; splenomegaly, 0% vs. 0%. The diagnostic sensitivity of fetal US for hepatomegaly and ventriculomegaly in FGR fetuses with cCMV was lower than that in non-FGR fetuses with cCMV. The prevalence of severe long-term sequelae (e.g., bilateral hearing impairment, epilepsy, cerebral palsy, and severe developmental delay) in the CMV-infected fetuses with FGR was higher, albeit non-significantly. Clinicians should keep in mind the possibility of overlooking the symptoms of cCMV in assessing fetuses with FGR.
    Jan. 2023, Diagnostics (Basel, Switzerland), 13(2) (2), English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 今福 仁美, 出口 雅士, 大路 剛, 寺井 義人
    「産婦人科の進歩」編集室, Aug. 2022, 産婦人科の進歩, 74(3) (3), 466 - 468, Japanese

  • 久保田 いろは, 今福 仁美, 益子 尚久, 福岡 秀規, 手島 直則, 谷村 憲司, 出口 雅士, 寺井 義人
    日本女性栄養・代謝学会, May 2022, 日本女性栄養・代謝学会誌, 27(2) (2), 131 - 131, Japanese

  • Naohisa Masuko, Kenji Tanimura, Nobue Kojima, Hitomi Imafuku, Masashi Deguchi, Yuko Okada, Yushi Hirota, Wataru Ogawa, Hideto Yamada
    AIM: The aim of this prospective cohort study was to evaluate the risk factors for postpartum glucose intolerance (GI) in women with gestational diabetes mellitus (GDM). METHOD: A total of 140 women with GDM were enrolled. Of these, 115 underwent a 75-g oral glucose tolerance test (OGTT) at 12 weeks after delivery. Clinical factors and parameters in the antepartum 75-g OGTT associated with postpartum GI were evaluated by logistic regression analyses. RESULTS: Twenty-two (19.1%) of the 115 women with GDM developed postpartum GI. The univariate and multivariable logistic regression analyses revealed that low oral disposition index (DI) was a risk factor for postpartum GI (OR, 0.2; 95% CI, 0.04-0.7; p < 0.05), and that no clinical factors were associated with postpartum GI. CONCLUSIONS: Lower oral DI on the antepartum 75-g OGTT may be a useful marker for identifying GDM women who are at high risk for postpartum GI.
    Jan. 2022, The journal of obstetrics and gynaecology research, English, International magazine
    Scientific journal

  • Kenji Tanimura, Akiko Uchida, Hitomi Imafuku, Shinya Tairaku, Kazumichi Fujioka, Ichiro Morioka, Hideto Yamada
    Congenital cytomegalovirus (CMV) infection may cause severe long-term sequelae. Recent studies have demonstrated that early antiviral therapy for infants with symptomatic congenital CMV (cCMV) infection may improve neurological outcomes; thus, accurate identification of newborns at high risk of cCMV infection may contribute to improved outcomes in affected children. However, maternal serological screening for cCMV infection by diagnosing primary infection during pregnancy, which is a popular screening strategy, is inefficient, because the number of cCMV infections with nonprimary causes, including reactivation of or reinfection with CMV, is larger than that of cCMV infections with primary causes. Low levels of neutralizing antibodies against pentameric complex and potent CMV-specific T cell-mediated immune responses are associated with an increased risk of cCMV infection. Conversely, our prospective cohort studies revealed that the presence of maternal fever/flu-like symptoms, threatened miscarriage/premature delivery, or actual premature delivery are risk factors for cCMV infection among both women with normal pregnancies and those with high-risk ones, regardless of whether the infection is primary or nonprimary. This review focused on host immune responses to human CMV and current knowledge of potential biological and clinical factors that are predictive of cCMV infection.
    Dec. 2021, International journal of molecular sciences, 22(24) (24), English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Kenji Tanimura, Yutoku Shi, Hitomi Imafuku, Takaaki Nakanishi, Maki Kanzawa, Yoshito Terai
    Placental mesenchymal dysplasia (PMD) is a rare placental abnormality that is closely related to severe pregnancy complications. A 27-year-old woman with fetal growth restriction and placenta previa was referred to a university hospital at 22 gestational weeks (GW). She was suspected of having a twin pregnancy with a complete or partial hydatidiform mole and coexisting normal live fetus, because two separate placentas, an enlarged one with multiple cystic lesions and a normal one, were shown on ultrasound examinations. At 27 GW, she experienced a sudden intrauterine fetal death (IUFD) after bleeding due to placenta previa, despite confirmation of fetal well-being at 2 h before bleeding. After delivery, histopathological examination confirmed the diagnosis of PMD. This is the first documented case of a woman with PMD and placenta previa who had a sudden IUFD after bleeding. Patients with both PMD and placenta previa should be considered at extremely high risk for IUFD.
    Nov. 2021, The journal of obstetrics and gynaecology research, 47(11) (11), 4087 - 4092, English, International magazine
    Link to Kobe Univ. Repository (Kernel)

  • 吉本 梓希子, 谷村 憲司, 久保田 いろは, 栖田 園子, 施 裕徳, 内田 明子, 白川 得朗, 今福 仁美, 出口 雅士, 寺井 義人
    「産婦人科の進歩」編集室, Oct. 2021, 産婦人科の進歩, 73(4) (4), 500 - 500, Japanese

  • Kenta Obata, Kenji Tanimura, Naohisa Masuko, Hitomi Imafuku, Moritoki Egi, Yoshito Terai
    A 40-year-old primigravida woman with a monochorionic-triamniotic (MT) triplet pregnancy was hospitalized due to threatened abortion at 16 gestational weeks. Polyhydramnios in two fetuses and oligohydramnios in the third supported a diagnosis of feto-fetal transfusion syndrome (FFTS) at 23 weeks and 3 days of gestation. Severe dyspnea and liver dysfunction required intensive care unit admission and mechanical ventilation support, and abdominal compartment syndrome (ACS) caused by polyhydramnios was clinically diagnosed. When her general condition was not improved regardless of intensive care, the patient delivered the three fetuses by cesarean section at 23 weeks and 5 days gestation. Abdominal decompression was achieved with delivery, and the patient was discharged 13 days after operation without morbidity. This is the first case report of ACS caused by FFTS in a MT triplet pregnancy resulting in extremely preterm birth.
    Sep. 2021, The journal of obstetrics and gynaecology research, 47(9) (9), 3370 - 3373, English, International magazine
    Link to Kobe Univ. Repository (Kernel)

  • Hitomi Imafuku, Kenji Tanimura, Yutoku Shi, Akiko Uchida, Masashi Deguchi, Yoshito Terai
    INTRODUCTION: Placenta accreta spectrum (PAS) is a life-threating obstetric complication, and prenatal prediction of PAS can decrease maternal morbidity and mortality. The aim of this prospective cohort study was to determine the clinical factors associated with PAS. METHODS: Pregnant women who delivered at a university hospital were enrolled. Clinical data were collected from medical records, and logistic regression analyses were performed to determine which clinical factors were associated with PAS. RESULTS: Eighty-seven (2.1%) of the 4146 pregnant women experienced PAS. Multivariable analyses revealed that a prior history of cesarean section (CS) (OR 3.3; 95% CI 1.9-5.7; p < 0.01), dilation and curettage (D&C) (OR 2.8; 95% CI 1.7-4.6; p < 0.01), hysteroscopic surgery (OR 5.7; 95% CI 2.3-14.4; p < 0.01), uterine artery embolization (UAE) (OR 44.1; 95% CI 13.8-141.0; p < 0.01), current pregnancy via assisted reproductive technology (ART) (OR 4.1; 95% CI 2.4-7.1; p < 0.01), and the presence of placenta previa in the current pregnancy (OR 13.1; 95% CI 7.9-21.8; p < 0.01) were independently associated with the occurrence of PAS. CONCLUSION: Pregnant women who have a prior history of CS, D&C, hysteroscopic surgery, UAE, current pregnancy via ART, and the presence of placenta previa in the current pregnancy are high risk for PAS.
    Sep. 2021, Placenta, 112, 180 - 184, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 非初感染母体から出生した重篤な症候性先天性サイトメガロウイルス感染症児の一例
    今福 仁美, 谷村 憲司, 益子 尚久, 内田 明子, 藤本 将史, 京野 由紀, 藤岡 一路, 出口 雅士, 寺井 義人
    (一社)日本周産期・新生児医学会, Jun. 2021, 日本周産期・新生児医学会雑誌, 57(Suppl.) (Suppl.), P163 - P163, Japanese

  • 非初感染母体から出生した重篤な症候性先天性サイトメガロウイルス感染症児の一例
    今福 仁美, 谷村 憲司, 益子 尚久, 内田 明子, 藤本 将史, 京野 由紀, 藤岡 一路, 出口 雅士, 寺井 義人
    (一社)日本周産期・新生児医学会, Jun. 2021, 日本周産期・新生児医学会雑誌, 57(Suppl.) (Suppl.), P163 - P163, Japanese

  • 胎児治療と新生児治療の併用は先天性サイトメガロウイルス感染症児の予後を改善する
    谷村 憲司, 施 裕徳, 内田 明子, 今福 仁美, 藤岡 一路, 森岡 一朗, 出口 雅士, 峰松 俊夫, 寺井 義人, 山田 秀人
    (一社)日本周産期・新生児医学会, Jun. 2021, 日本周産期・新生児医学会雑誌, 57(Suppl.) (Suppl.), P177 - P177, Japanese

  • トキソプラズマ-IgG avidity index高値母体から発生した先天性トキソプラズマ感染疑いの1例
    谷村 憲司, 内田 明子, 笹川 勇樹, 施 裕徳, 白川 得朗, 今福 仁美, 出口 雅士, 芦名 満理子, 藤岡 一路, 森岡 一朗, 笹井 美和, 山本 雅裕, 山田 秀人
    (一社)日本産婦人科感染症学会, May 2021, 日本産婦人科感染症学会学術講演会プログラム・抄録集, 37回, 53 - 53, Japanese

  • 益子 尚久, 谷村 憲司, 小畑 権大, 今福 仁美, 出口 雅士, 寺井 義人
    「産婦人科の進歩」編集室, May 2021, 産婦人科の進歩, 73(2) (2), 137 - 137, Japanese

  • 梅毒合併妊娠8例の検討
    出口 雅士, 谷村 憲司, 施 裕徳, 内田 明子, 白川 得朗, 今福 仁美, 森實 真由美, 山田 秀人
    (一社)日本産婦人科感染症学会, May 2021, 日本産婦人科感染症学会学術講演会プログラム・抄録集, 37回, 43 - 43, Japanese

  • 周産期母子医療センターでの先天性サイトメガロウイルス感染に関与する臨床所見
    今福 仁美, 谷村 憲司, 内田 明子, 施 裕徳, 笹川 勇樹, 白川 得朗, 出口 雅士, 山田 秀人
    (一社)日本産婦人科感染症学会, May 2021, 日本産婦人科感染症学会学術講演会プログラム・抄録集, 37回, 50 - 50, Japanese

  • 谷村 憲司, 施 裕徳, 内田 明子, 上中 美月, 今福 仁美, 藤岡 一路, 森岡 一朗, 出口 雅士, 寺井 義人, 山田 秀人
    「産婦人科の進歩」編集室, May 2021, 産婦人科の進歩, 73(2) (2), 152 - 152, Japanese

  • Kenji Tanimura, Yutoku Shi, Akiko Uchida, Mizuki Uenaka, Hitomi Imafuku, Toshihiko Ikuta, Kazumichi Fujioka, Ichiro Morioka, Masashi Deguchi, Toshio Minematsu, Hideto Yamada
    Infants with symptomatic congenital cytomegalovirus infection (cCMV) suffer from long-term sequelae. This study aimed at evaluating the efficacy of combining immunoglobulin (Ig) fetal therapy (FT) and neonatal therapy (NT) with antiviral drugs to improve neurological outcomes of affected infants. Women whose fetuses had symptomatic cCMV received Ig injection into the fetal peritoneal cavity and/or maternal blood as FT, while affected newborns received oral valganciclovir or intravenous ganciclovir as NT. We compared the neurological outcomes at ≥18 months old between infants receiving FT with or without NT (FT group) and those receiving NT only (NT group). From 2009-2019, 15 women whose fetuses had symptomatic cCMV received FT, while 19 newborns received NT only. In FT group, two newborns died, and two were <18 months old. Neurological outcomes of the remaining 11 infants in FT group were as follows: normal 45.5 %, mild impairments 36.4 %, and severe impairments 18.2 %. In NT group, one newborn died, one's parents refused the follow-up, one was <18 months old, and two had only chorioretinitis as symptoms. Neurological outcomes of the remaining 14 infants in NT group were as follows: normal 21.4 %, mild impairments 14.3 %, and severe impairments 64.3 %. The proportion of infants with severe impairments in FT group was significantly lower than that in NT group (18.2 % vs 64.3 %, p < 0.05). This is the first trial demonstrating that the combination of Ig FT and NT with antiviral drugs may be more effective in improving neurological outcomes of newborns with symptomatic cCMV as compared to NT only.
    Dec. 2020, Journal of reproductive immunology, 143, 103263 - 103263, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Hitomi Imafuku, Hideto Yamada, Akiko Uchida, Masashi Deguchi, Tokuro Shirakawa, Yuki Sasagawa, Yutoku Shi, Kazumichi Fujioka, Ichiro Morioka, Kenji Tanimura
    This prospective cohort study aimed to determine clinical factors associated with congenital cytomegalovirus (CMV) infection in pregnancy. Newborns born at a perinatal medical center received PCR analyses for CMV-DNA in their urine with informed consent. Clinical data, including age, maternal fever or flu-like symptoms, complications, ultrasound fetal abnormality, gestational weeks at delivery, and birth weight, were collected. Logistic regression analyses determined clinical findings associated with congenital CMV infection (cCMV). cCMV was diagnosed in 32 of 4380 pregnancies. Univariate and multivariable analyses revealed that age < 25 years old (OR 2.7, 95% CI 1.1-6.6; p < 0.05), the presence of maternal fever or flu-like symptoms (5.4, 2.6-11.2; p < 0.01), ultrasound fetal abnormalities (12.7, 5.8-27.7; p < 0.01), and preterm delivery at less than 34 gestational weeks (2.6, 1.1-6.0; p < 0.05) were independent clinical findings associated with cCMV. A combination of maternal fever/flu-like symptoms, ultrasound fetal abnormalities, or preterm delivery at less than 34 gestational weeks as optimal predictive factors showed 90.6% sensitivity, 66.4% specificity, and a maximum Youden index of 0.57. CMV-DNA tests in the urine of newborns born to mothers with these clinical manifestations may be an effective method in detecting cCMV as a targeted screening with a high sensitivity.
    Nov. 2020, Scientific reports, 10(1) (1), 19706 - 19706, English, International magazine
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 精神疾患合併妊娠の妊娠中・産後増悪誘因ならびに児への影響に関する検討
    谷村 憲司, 施 裕徳, 内田 明子, 笹川 勇樹, 白川 得朗, 今福 仁美, 出口 雅士, 山田 秀人
    「産婦人科の進歩」編集室, Oct. 2020, 産婦人科の進歩, 72(4) (4), 458 - 458, Japanese

  • トキソプラズマIgG avidity index高値母体から発生した先天性トキソプラズマ感染疑いの1例
    谷村 憲司, 笹川 勇樹, 内田 明子, 今福 仁美, 出口 雅士, 藤岡 一路, 森岡 一朗, 笹井 美和, 山本 雅裕, 山田 秀人
    「産婦人科の進歩」編集室, May 2020, 産婦人科の進歩, 72(2) (2), 162 - 162, Japanese

  • 妊娠糖尿病妊婦におけるHeavy For Date児出生の予測因子
    益子 尚久, 谷村 憲司, 施 裕徳, 内田 明子, 笹川 勇樹, 白川 得郎, 今福 仁美, 出口 雅士, 山田 秀人
    「産婦人科の進歩」編集室, May 2020, 産婦人科の進歩, 72(2) (2), 177 - 177, Japanese

  • Yukiko Nakasuji, Kenji Tanimura, Yuki Sasagawa, Hitomi Imafuku, Mayumi Morizane, Kazumichi Fujioka, Goh Ohji, Hideto Yamada
    Congenital syphilis may lead to severe sequelae in affected infants. The prevalence of syphilis in women of childbearing age has increased worldwide. From 2015 to 2018, we encountered eight pregnant women with syphilis including six with late latent and two with early latent syphilis. Seven pregnant women with syphilis received antibiotic therapies of oral amoxicillin, intravenous penicillin G, or the both. The syphilotherapies in four cases were considered effective, because rapid plasma reagin titers decreased. None of the seven pregnant women who received syphilotherapies had congenital syphilis. The remaining one woman who did not undergo a maternity checkup or syphilotherapy delivered a stillbirth with congenital syphilis at 29 gestational weeks.
    Mar. 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 26(3) (3), 298 - 300, English, International magazine
    [Refereed]
    Link to Kobe Univ. Repository (Kernel)

  • Hitomi Imafuku, Hideto Yamada, Mayumi Morizane, Kenji Tanimura
    AIM: To evaluate pregnancy outcome and complications in subsequent pregnancies after severe post-partum hemorrhage (PPH) between women with and without a history of uterine artery embolization (UAE). METHODS: Women who had a history of severe PPH, and delivered newborns at ≥22 gestational weeks in subsequent pregnancies were enrolled. Severe PPH was defined as blood loss volume of more than 2000 mL. RESULTS: The blood loss volume (median 1581 mL) in women with UAE (n = 14) was significantly more than that in women without UAE (median 1021 mL, n = 32, P < 0.01), and the recurrence rate of severe PPH in women with UAE (n = 5, 35.7%) was significantly higher than that in women without UAE (n = 3, 9.4%, P < 0.05). There were no significant differences in frequencies of premature delivery, hypertensive disorders of pregnancy, fetal growth restriction, or placenta previa/low lying placenta. Of 14 women with UAE, 7 (50.0%) had abnormally invasive placenta, whereas of 32 women without UAE, none had abnormally invasive placenta. CONCLUSION: Subsequent pregnancies after UAE for severe PPH had high risks for recurrence of severe PPH.
    Jan. 2020, The journal of obstetrics and gynaecology research, 46(1) (1), 119 - 123, English, International magazine
    [Refereed]
    Scientific journal

  • 子宮頸部上皮内新生物(CIN)合併妊娠における保存的管理に関する検討
    木原 智子, 蝦名 康彦, 今福 仁美, 長又 哲史, 上中 美月, 鈴木 嘉穂, 出口 雅士, 山田 秀人
    日本女性栄養・代謝学会, Sep. 2019, 日本女性栄養・代謝学会学術集会プログラム・抄録集, 43回, 64 - 64, Japanese

  • 症候性先天性サイトメガロウイルス感染症に対する胎児治療と新生児治療の有効性
    谷村 憲司, 内田 明子, 今福 仁美, 森實 真由美, 出口 雅士, 藤岡 一路, 森岡 一朗, 峰松 俊夫, 山田 秀人
    (一社)日本産婦人科感染症学会, Sep. 2019, 日本産婦人科感染症学会誌, 3(1) (1), 87 - 87, Japanese

  • 症候性先天性サイトメガロウイルス感染症に対する胎児治療と新生児治療の有効性
    谷村 憲司, 内田 明子, 今福 仁美, 森實 真由美, 出口 雅士, 藤岡 一路, 森岡 一朗, 峰松 俊夫, 山田 秀人
    (一社)日本産婦人科感染症学会, Sep. 2019, 日本産婦人科感染症学会誌, 3(1) (1), 87 - 87, Japanese

  • Yoshiya Miyahara, Hitomi Imafuku, Yuka Murata, Yasuhiko Ebina, Hideto Yamada
    S.O.G. CANADA Inc., 2019, European Journal of Gynaecological Oncology, 40(4) (4), 563 - 566, English
    Scientific journal

  • 宮地 真帆, 出口 雅士, 今福 仁美, 谷村 憲司, 森實 真由美, 蝦名 康彦, 山田 秀人
    (公社)日本母性衛生学会, Sep. 2018, 母性衛生, 59(3) (3), 293 - 293, Japanese

  • 今福 仁美, 森實 真由美, 谷村 憲司, 出口 雅士, 山田 秀人
    (公社)日本母性衛生学会, Sep. 2018, 母性衛生, 59(3) (3), 311 - 311, Japanese

  • 黒島 瑞穂, 谷村 憲司, 笹川 勇樹, 白川 得朗, 今福 仁美, 森實 真由美, 出口 雅士, 山田 秀人
    (一社)日本周産期・新生児医学会, Jun. 2018, 日本周産期・新生児医学会雑誌, 54(2) (2), 615 - 615, Japanese

  • 谷村 憲司, 内田 明子, 今福 仁美, 森實 真由美, 出口 雅士, 藤岡 一路, 森岡 一朗, 峰松 俊夫, 山田 秀人
    (一社)日本周産期・新生児医学会, Jun. 2018, 日本周産期・新生児医学会雑誌, 54(2) (2), 638 - 638, Japanese

  • Ebina Y, Uchiyama M, Imafuku Hitomi, Suzuki K, Miyahara Y, Yamada Hideto
    We aim to clarify the incidence of deep venous thrombosis (DVT) before treatment in women with ovarian cancer and identify risk factors for DVT.In this prospective study, 110 women underwent venous ultrasonography before cancer treatment and D-dimer levels were measured. We investigated factors predicting DVT by logistic regression.DVT was detected in 25 of 110 women (22.7%) and pulmonary thromboembolism was coexisted in 2 women (1.8%). A total of 21 women (84.4%) with DVT were asymptomatic. D-dimer levels in women with DVT (median, 10.9; range, <0.5-98.2 μg/mL) were significantly higher than those in women without DVT (2.0; <0.5-60.8 μg/mL; P < .01). When 10.9 μg/mL was used as a cutoff value for D-dimer levels to predict DVT, specificity, sensitivity, and positive and negative predictive values were 92.9%, 52.0%, 68.4%, and 86.8%, respectively. The multivariate analysis demonstrated that D-dimer level (odds ratio [OR], 19.7; 95% confidence interval [CI], 5.89-76.76) and clear cell histology (OR, 7.1; 95% CI, 2.12-25.67) were independent factors predicting DVT.Asymptomatic DVT occurred with great frequency before treatment in patients with ovarian cancer. High D-dimer level and clear cell pathology is associated with a higher DVT risk.
    Jun. 2018, Medicine (Baltimore), 97(23) (23), e11009, English, International magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • Ultrasound and MRI Findings of Twin Pregnancies with Complete Hydatidiform Mole and Coexisting Normal Fetus: Two Case Reports.
    Hitomi Imafuku, Yoshiya Miyahara, Yasuhiko Ebina, Hideto Yamada
    BACKGROUND: Both twin pregnancies with complete hydatidiform mole and coexisting normal fetus (CHMCF) and partial hydatidiform mole can be found in association with a live fetus and a placenta displaying a molar degeneration. Two cases of CHMCF using magnetic resonance imaging (MRI) for a diagnosis are reported. CASE: In the first, CHMCF was suspected at 12 weeks of gestation. At 18 weeks of gestation, the existence of molar placenta and a sac separating from fetus and normal placenta was clearly depicted on MRI. At 19 weeks of gestations, she had termination of pregnancy because of a development of gestational trophoblastic neoplasia (GTN) and started chemotherapy. In the second case, CHMCF was suspected at 14 weeks of gestation. MRI demonstrated the existence of molar placenta and a sac separating from fetus and normal placenta. She chose induced abortion and there was no evidence of GTN during the 1 year-follow up period. Pathological examination in both cases was consistent with a complete hydration mole and a coexisting normal female fetus. CONCLUSION: MRI was useful for an accurate diagnosis for CHMCF.
    May 2018, The Kobe journal of medical sciences, 64(1) (1), E1-E5 - E5, English, Domestic magazine
    [Refereed]
    Scientific journal
    Link to Kobe Univ. Repository (Kernel)

  • 鈴木 嘉穂, 蝦名 康彦, 長又 哲史, 白川 得朗, 今福 仁美, 若橋 宣, 宮原 義也
    (一社)日本産科婦人科内視鏡学会, Apr. 2018, 日本産科婦人科内視鏡学会雑誌, 34(1) (1), 174 - 178, Japanese

  • 子宮頸部細胞診AGC症例の病理組織学的検討と転帰
    川口 徹也, 蝦名 康彦, 今福 仁美, 鈴木 嘉穂, 若橋 宣, 宮原 義也, 山田 秀人
    「産婦人科の進歩」編集室, Oct. 2017, 産婦人科の進歩, 69(4) (4), 507 - 507, Japanese

  • 当科におけるアテロコラーゲン膜を用いた造腟術の成績
    宮原 義也, 今福 仁美, 鈴木 嘉穂, 若橋 宣, 蝦名 康彦, 山田 秀人
    (一社)日本産科婦人科内視鏡学会, Aug. 2017, 日本産科婦人科内視鏡学会雑誌, 33(Suppl.I) (Suppl.I), 616 - 616, Japanese

  • 子宮体部病変に対する病理診断が困難な症例においてFDG-PET検査は治療方針決定に有用である
    鈴木 嘉穂, 今福 仁美, 若橋 宣, 宮原 義也, 蝦名 康彦, 山田 秀人
    (公社)日本婦人科腫瘍学会, Jun. 2017, 日本婦人科腫瘍学会雑誌, 35(3) (3), 555 - 555, Japanese

  • 上中 美月, 鈴木 嘉穂, 今福 仁美, 若橋 宣, 宮原 義也, 蝦名 康彦, 山田 秀人
    「産婦人科の進歩」編集室, May 2017, 産婦人科の進歩, 69(2) (2), 222 - 222, Japanese

  • 今福 仁美, 宮原 義也, 鈴木 嘉穂, 若橋 宣, 市田 耕太郎, 蝦名 康彦, 山田 秀人
    「産婦人科の進歩」編集室, May 2017, 産婦人科の進歩, 69(2) (2), 238 - 238, Japanese

  • 今福 仁美, 蝦名 康彦, 鈴木 嘉穂, 若橋 宣, 宮原 義也, 森田 宏紀, 山田 秀人
    「産婦人科の進歩」編集室, May 2016, 産婦人科の進歩, 68(2) (2), 212 - 212, Japanese

  • 子宮内膜細胞診陽性と判定するも組織学的に体癌の診断にいたらなかった2症例の検討
    森上聡子, 蝦名康彦, 今福仁美, 鈴木嘉穂, 篠崎奈々絵, 塚本龍子, Hara Shigeo, 伊藤智雄, 山田秀人
    Apr. 2016, 日本臨床細胞学会雑誌, 55(Suppl.1) (Suppl.1), 191, Japanese
    Research society

  • ASC-H症例の病理組織診断および臨床経過に関する検討
    今福仁美, 蝦名康彦, 白川得朗, 鈴木嘉穂, 篠崎奈々絵, 塚本龍子, Hara Shigeo, 伊藤智雄, 山田秀人
    Oct. 2015, 日本臨床細胞学会雑誌, 54(Suppl.2) (Suppl.2), 546, Japanese
    [Refereed]
    Research society

  • 子宮体癌根治術における廓清リンパ節および子宮筋層にリンパ脈管筋腫症細胞を認めた一例
    森田 宏紀, 山崎 友維, 白川 友香, 平久 進也, 鈴木 嘉穂, 今福 仁美, 生橋 義之, 出口 雅士, 宮原 義也, 新谷 潔, 蝦名 康彦, 川上 史, 山田 秀人
    (公社)日本婦人科腫瘍学会, Jun. 2014, 日本婦人科腫瘍学会雑誌, 32(3) (3), 590 - 590, Japanese
    [Refereed]

■ MISC
  • 益子 尚久, 花房 宏昭, 濱 真奈美, 田中 敬子, 前田 美亜, 冨本 雅子, 今福 仁美, 粟野 宏之, 出口 雅士, 寺井 義人, 野津 寛大
    (一社)日本遺伝カウンセリング学会, Jun. 2023, 日本遺伝カウンセリング学会誌, 44(2) (2), 156 - 156, Japanese

  • 胎児治療と新生児治療の併用は先天性サイトメガロウイルス感染症児の予後を改善する
    谷村 憲司, 施 裕徳, 内田 明子, 今福 仁美, 藤岡 一路, 森岡 一朗, 出口 雅士, 峰松 俊夫, 寺井 義人, 山田 秀人
    (一社)日本周産期・新生児医学会, Jun. 2021, 日本周産期・新生児医学会雑誌, 57(Suppl.) (Suppl.), P177 - P177, Japanese

  • 産科一次施設における先天性サイトメガロウイルス感染症発生の臨床的リスク因子
    内田 明子, 谷村 憲司, 今福 仁美, 笹川 勇樹, 施 裕徳, 白川 得朗, 出口 雅士, 森實 真由美, 大橋 正伸, 山田 秀人
    (一社)日本産婦人科感染症学会, May 2021, 日本産婦人科感染症学会学術講演会プログラム・抄録集, 37回, 52 - 52, Japanese

  • 非初感染母体から出生した重篤な症候性先天性サイトメガロウイルス感染症児の一例
    今福仁美, 谷村憲司, 益子尚久, 内田明子, 藤本将史, 京野由紀, 藤岡一路, 出口雅士, 寺井義人
    2021, 日本周産期・新生児医学会雑誌(Web), 57(Suppl) (Suppl)

  • 不育症と子宮内膜マイクロバイオームとの関連
    施裕徳, 谷村憲司, 笹川勇樹, 内田明子, 尾崎可奈, 白川得朗, 今福仁美, 出口雅士, 山田秀人
    2021, 日本産婦人科感染症学会学術講演会プログラム・抄録集, 37th

  • 子宮頸部細胞診ASC-H判定例の臨床的取り扱い 病理組織診断および転帰に関する検討
    今福 仁美, 蝦名 康彦
    (公社)日本臨床細胞学会, Jul. 2019, 日本臨床細胞学会雑誌, 58(4) (4), 162 - 166, Japanese

  • 正常胎児と全奇胎の双胎(complete hydatidiform mole coexistent with a fetus)の3症例
    吉澤 ひかり, 蝦名 康彦, 今福 仁美, 鈴木 嘉穂, 若橋 宣, 宮原 義也, 出口 雅士, 山田 秀人
    「産婦人科の進歩」編集室, Feb. 2019, 産婦人科の進歩, 71(1) (1), 9 - 16, Japanese

  • 不育症のトピックス 不育症とネオ・セルフ
    谷村 憲司, 笹川 勇樹, 今福 仁美, 森實 真由美, 出口 雅士, 蝦名 康彦, 荒瀬 規子, 荒瀬 尚, 齋藤 滋, 山田 秀人
    (一社)日本生殖医学会, Aug. 2018, 日本生殖医学会雑誌, 63(3) (3), 230 - 230, Japanese

  • Yasuhiko Ebina, Yuka Murata, Erika Tanaka, Hitomi Imafuku, Kaho Suzuki, Yoshiya Miyahara, Hideto Yamada
    Nov. 2016, JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 118, 125 - 125, English
    Summary international conference

  • P3-6-1 婦人科悪性腫瘍治療前患者における深部静脈血栓症のリスク因子の検討(Group 71 深部静脈血栓・肺塞栓症・脳梗塞,一般演題,公益社団法人日本産科婦人科学会第68回学術講演会)
    内山 美穂子, 蝦名 康彦, 今福 仁美, 鈴木 嘉穂, 宮原 義也, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2016, 日本産科婦人科學會雜誌, 68(2) (2), 831 - 831, Japanese

  • P2-31-11 子宮頸癌IB期・II期の検討 : 手術療法と放射線療法の比較(Group31 子宮頸癌・治療2・合併症・予後因子,一般演題,公益社団法人日本産科婦人科学会第68回学術講演会)
    今福 仁美, 蝦名 康彦, 鈴木 嘉穂, 宮原 義也, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2016, 日本産科婦人科學會雜誌, 68(2) (2), 699 - 699, Japanese

  • P2-7-8 骨盤リンパ膿瘍における経皮的CTガイド下ドレナージに関する検討(Group48 感染症,一般演題,公益社団法人日本産科婦人科学会第67回学術講演会)
    田中 恵里加, 宮原 義也, 白川 友香, 今福 仁美, 鈴木 嘉穂, 生橋 義之, 新谷 潔, 蝦名 康彦, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2015, 日本産科婦人科學會雜誌, 67(2) (2), 668 - 668, Japanese

  • P2-4-5 PET-CT所見で決定した進行子宮頸癌の放射線療法照射範囲と予後(Group45 子宮頸部腫瘍 症例検討,一般演題,公益社団法人日本産科婦人科学会第67回学術講演会)
    鈴木 嘉穂, 蝦名 康彦, 今福 仁美, 宮原 義也, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2015, 日本産科婦人科學會雜誌, 67(2) (2), 657 - 657, Japanese

  • P2-24-3 子宮体癌根治術における廓清リンパ節および子宮筋層に認めたリンパ脈管筋腫症細胞(Group 65 良性・悪性腫瘍 症例1,一般演題,公益社団法人日本産科婦人科学会第67回学術講演会)
    森田 宏紀, 今福 仁美, 鈴木 嘉穂, 生橋 義之, 新谷 潔, 宮原 義也, 蝦名 康彦, 山田 秀人
    日本産科婦人科学会, 2015, 日本産科婦人科學會雜誌, 67(2) (2), 711 - 711, Japanese

  • P3-5-4 子宮頸癌放射線療法の検討 : 放射線単独療法と同時化学放射線療法の比較(Group 107 子宮頸部腫瘍 治療2,一般演題,第67回学術講演会)
    今福 仁美, 蝦名 康彦, 宮原 義也, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2015, 日本産科婦人科學會雜誌, 67(2) (2), 830 - 830, Japanese

  • P1-2-7 子宮頸部上皮内病変に対するHPVタイピング検査を併用した管理と治療(Group2 CIN診断,治療,その他2,一般演題,公益社団法人日本産科婦人科学会第67回学術講演会)
    施 裕徳, 蝦名 康彦, 今福 仁美, 宮原 義也, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2015, 日本産科婦人科學會雜誌, 67(2) (2), 537 - 537, Japanese

  • P1-3-4 子宮頸部円錐切除術例の治療成績と妊娠予後(Group3 CIN診断,治療,その他3,一般演題,公益社団法人日本産科婦人科学会第67回学術講演会)
    白川 友香, 蝦名 康彦, 今福 仁美, 宮原 義也, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2015, 日本産科婦人科學會雜誌, 67(2) (2), 539 - 539, Japanese

  • P3-13-3 巨大卵巣腫瘍の診断と術後管理に関する検討(Group 115 卵巣腫瘍 治療1 進行癌の治療,一般演題,第67回学術講演会)
    宮原 義也, 今福 仁美, 鈴木 嘉穂, 生橋 義之, 新谷 潔, 蝦名 康彦, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2015, 日本産科婦人科學會雜誌, 67(2) (2), 849 - 849, Japanese

  • 卵巣奇形腫における悪性転化の術前予測についての検討
    牧原夏子, 蝦名康彦, 山崎友維, 今福仁美, 生橋義之, 松岡正造, 宮原義也, 新谷潔, 森田宏紀, 山田秀人
    日本産科婦人科学会, 01 Feb. 2014, 日本産科婦人科学会雑誌, 66(2) (2), 627 - 627, Japanese

  • P2-42-12 癒着胎盤における絨毛細胞の上皮間葉変換に関する解析(Group 80 産科出血4,一般演題,第66回学術講演会)
    白川 得朗, 宮原 義也, 今福 仁美, 牧原 夏子, 蝦名 康彦, 山田 秀人
    日本産科婦人科学会, 2014, 日本産科婦人科學會雜誌, 66(2) (2), 703 - 703, Japanese

  • P1-18-4 婦人科癌術前PET-CTで発見された重複癌症例に関する臨床的検討(Group 18 悪性腫瘍全般・診断1,一般演題,公益社団法人日本産科婦人科学会第66回学術講演会)
    新谷 潔, 蝦名 康彦, 西本 昌司, 山崎 友維, 今福 仁美, 生橋 義之, 宮原 義也, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2014, 日本産科婦人科學會雜誌, 66(2) (2), 518 - 518, Japanese

  • P3-39-2 ASC-H症例の臨床経過と細胞診所見に関する検討(Group 136 子宮頸部腫瘍・検診1,一般演題,公益社団法人日本産科婦人科学会第66回学術講演会)
    今福 仁美, 蝦名 康彦, 西本 昌司, 山崎 友維, 生橋 義之, 新谷 潔, 宮原 義也, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2014, 日本産科婦人科學會雜誌, 66(2) (2), 871 - 871, Japanese

  • P3-44-9 転移性子宮腫瘍の診断に腹水セルブロック法が有用であった2症例(Group 141 子宮体部腫瘍・診断2,一般演題,公益社団法人日本産科婦人科学会第66回学術講演会)
    生橋 義之, 蝦名 康彦, 西本 昌司, 山崎 友維, 今福 仁美, 新谷 潔, 宮原 義也, 森田 宏紀, 山田 秀人
    日本産科婦人科学会, 2014, 日本産科婦人科學會雜誌, 66(2) (2), 885 - 885, Japanese

  • 術前GnRH療法および術後ジエノゲスト療法を併用した水腎症合併重症子宮内膜症の2例
    蝦名康彦, 上田萩子, 西本昌司, 山崎友維, 今福仁美, 生橋義之, 宮原義也, 新谷潔, 森田宏紀, 山田秀人
    2014, 日本エンドメトリオーシス学会プログラム・抄録集, 35th, 96, Japanese

■ Lectures, oral presentations, etc.
  • 母子感染：予防と対策 兵庫県の妊婦梅毒症例からみた梅毒母子感染の予防と対策における課題
    MORIZANE MAYUMI, TANIMURA KENJI, IMAFUKU HITOMI, SHIRAKAWA TOKURO, UENAKA MIZUKI, SASAGAWA YUUKI, SHIMAOKA MASAO, YAMADA HIDETO
    第63回日本新生児成育医学会学術集会, Nov. 2018, Japanese, 東京, Domestic conference
    Nominated symposium

  • 切迫流早産と腟内マイクロバイオームとの関連性
    施 裕徳, TANIMURA KENJI, SASAGAWA YUUKI, 内田 明子, UENAKA MIZUKI, SHIRAKAWA TOKURO, IMAFUKU HITOMI, SHIMAOKA MASAO, MORIZANE MAYUMI, YAMADA HIDETO
    第33回日本生殖免疫学会総会・学術集会, Nov. 2018, Japanese, 東京, Domestic conference
    Oral presentation

  • 維持透析療法を要した腎不全合併妊娠4例
    IMAFUKU HITOMI, TANIMURA KENJI, SASAGAWA YUUKI, UENAKA MIZUKI, SHIRAKAWA TOKURO, SHIMAOKA MASAO, MORIZANE MAYUMI, YAMADA HIDETO
    第39回日本妊娠高血圧学会学術集会, Nov. 2018, Japanese, 大阪, Domestic conference
    Oral presentation

  • 分娩後出血に対するUAEの帰結およびUAE後の妊娠についての検討
    IMAFUKU HITOMI, MORIZANE MAYUMI, TANIMURA KENJI, DEGUCHI MASASHI, YAMADA HIDETO
    第59回日本母性衛生学会総会・学術集会, Oct. 2018, Japanese, 新潟, Domestic conference
    Poster presentation

  • 梅毒合併妊娠の7例
    中筋由紀子, TANIMURA KENJI, IMAFUKU HITOMI, MORIZANE MAYUMI, YAMADA HIDETO
    第59回日本母性衛生学会総会・学術集会, Oct. 2018, Japanese, 新潟, Domestic conference
    Oral presentation

  • 神戸大学における不育症の臨床因子と妊娠予後の検討
    宮地 真帆, DEGUCHI MASASHI, IMAFUKU HITOMI, TANIMURA KENJI, MORIZANE MAYUMI, EBINA YASUHIKO, YAMADA HIDETO
    第59回日本母性衛生学会総会・学術集会, Oct. 2018, Japanese, 新潟, Domestic conference
    Poster presentation

  • Risk factors for deep venous thrombosis in women with ovarian cancer
    Yasuhiko Ebina, Hitomi Imafuku, Kaho Suzuki, Yoshiya Miyahara, Hideto Yamada
    第56回日本癌治療学会, Oct. 2018, English, 横浜, Domestic conference
    Poster presentation

  • 不育症のトピックス～不育症とネオ・セルフ
    TANIMURA KENJI, SASAGAWA YUUKI, IMAFUKU HITOMI, MORIZANE MAYUMI, DEGUCHI MASASHI, EBINA YASUHIKO, 荒瀬 規子, 荒瀬 尚, 齋藤 滋, YAMADA HIDETO
    第63回日本生殖医学会学術講演会・総会, Sep. 2018, Japanese, 旭川, Domestic conference
    Nominated symposium

  • Pregnancy outcomes subsequent to uterine arterial embolization for severe post-partum hemorrhage
    Mayumi Morizane, Hitomi Imafuku, SHIRAKAWA TOKURO, Kenji Tanimura, Masashi Deguchi, Hideto Yamada
    The 20th congress of federation of asia oceania perinatal societies (FAOPS), Sep. 2018, English, Manila, International conference
    Poster presentation

  • 梅毒合併妊娠の7症例
    中筋由紀子, TANIMURA KENJI, IMAFUKU HITOMI, MORIZANE MAYUMI, FUJIOKA KAZUMICHI, OHJI GO, YAMADA HIDETO
    第41回日本母体胎児医学会学術集会, Aug. 2018, Japanese, 東京, Domestic conference
    Oral presentation

  • 兵庫県産婦人科施設を対象とした梅毒アンケート調査結果と今後の課題
    MORIZANE MAYUMI, 廣瀬 雅哉, TANIMURA KENJI, IMAFUKU HITOMI, SHIRAKAWA TOKURO, UENAKA MIZUKI, SASAGAWA YUUKI, SHIMAOKA MASAO, YAMADA HIDETO
    第92回兵庫県産婦人科学会学術集会, Jul. 2018, Japanese, 神戸, Domestic conference
    Oral presentation

  • 兵庫県における女性の梅毒症例の動向と課題
    MORIZANE MAYUMI, TANIMURA KENJI, IMAFUKU HITOMI, SHIRAKAWA TOKURO, UENAKA MIZUKI, SASAGAWA YUUKI, SHIMAOKA MASAO, YAMADA HIDETO
    第54回日本周産期・新生児医学会学術集会, Jul. 2018, Japanese, 東京, Domestic conference
    Oral presentation

  • 切迫早産と腟内マイクロバイオームとの関連性の検討
    SASAGAWA YUUKI, TANIMURA KENJI, 施 裕徳, 内田 明子, UENAKA MIZUKI, SHIRAKAWA TOKURO, IMAFUKU HITOMI, SHIMAOKA MASAO, MORIZANE MAYUMI, YAMADA HIDETO
    第92回兵庫県産婦人科学会学術集会, Jul. 2018, Japanese, 神戸, Domestic conference
    Oral presentation

  • 症候性の先天性サイトメガロウイルス感染症に対する胎児治療と新生児治療
    TANIMURA KENJI, 内田 明子, IMAFUKU HITOMI, MORIZANE MAYUMI, DEGUCHI MASASHI, FUJIOKA KAZUMICHI, MORIOKA ICHIRO, 峰松 俊夫, YAMADA HIDETO
    第54回日本周産期・新生児医学会学術集会, Jul. 2018, Japanese, 東京, Domestic conference
    Oral presentation

  • 最近管理した梅毒合併妊婦7症例
    中筋由紀子, TANIMURA KENJI, 施 裕徳, 内田 明子, UENAKA MIZUKI, SHIRAKAWA TOKURO, IMAFUKU HITOMI, 島岡 昌夫, MORIZANE MAYUMI, YAMADA HIDETO
    第92回兵庫県産婦人科学会学術集会, Jul. 2018, Japanese, 神戸, Domestic conference
    Oral presentation

  • 維持透析療法を要した腎不全合併妊娠3例
    黒島 瑞穂, TANIMURA KENJI, SASAGAWA YUUKI, SHIRAKAWA TOKURO, IMAFUKU HITOMI, MORIZANE MAYUMI, DEGUCHI MASASHI, YAMADA HIDETO
    第54回日本周産期・新生児医学会学術集会, Jul. 2018, Japanese, 東京, Domestic conference
    Oral presentation

  • UAE後の妊娠では産後出血に注意が必要である
    IMAFUKU HITOMI, MORIZANE MAYUMI, SASAGAWA YUUKI, UENAKA MIZUKI, SHIRAKAWA TOKURO, SHIMAOKA MASAO, TANIMURA KENJI, YAMADA HIDETO
    第54回日本周産期・新生児医学会学術集会, Jul. 2018, Japanese, 東京, Domestic conference
    Oral presentation

  • CIN2患者に対するレーザー蒸散術の検討（第二報）
    EBINA YASUHIKO, UENAKA MIZUKI, IMAFUKU HITOMI, NAGAMATA SATOSHI, SUZUKI KAHO, MIYAHARA YOSHIYA, DEGUCHI MASASHI, YAMADA HIDETO
    第92回兵庫県産婦人科学会学術集会, Jul. 2018, Japanese, 神戸, Domestic conference
    Oral presentation

  • 子宮頚部上皮内新生物（CIN）合併妊娠における保存的管理に関する検討
    白國あかり, EBINA YASUHIKO, IMAFUKU HITOMI, NAGAMATA SATOSHI, UENAKA MIZUKI, SUZUKI KAHO, WAKAHASHI SENN, MIYAHARA YOSHIYA, DEGUCHI MASASHI, YAMADA HIDETO
    第138回近畿産科婦人科学会総会, Jun. 2018, Japanese, 大阪, Domestic conference
    Oral presentation

  • 兵庫県における女性梅毒症例の動向と課題
    MORIZANE MAYUMI, TANIMURA KENJI, IMAFUKU HITOMI, SHIRAKAWA TOKURO, UENAKA MIZUKI, SASAGAWA YUUKI, YAMADA HIDETO
    第35回日本産婦人科感染症学会学術集会, May 2018, Japanese, 岐阜, Domestic conference
    Oral presentation

  • 症候性の先天性サイトメガロウイルス感染症に対する胎児治療と新生児治療の有効性
    TANIMURA KENJI, 内田 明子, IMAFUKU HITOMI, MORIZANE MAYUMI, DEGUCHI MASASHI, FUJIOKA KAZUMICHI, MORIOKA ICHIRO, 峰松 俊夫, YAMADA HIDETO
    第35回日本産婦人科感染症学会学術集会, May 2018, Japanese, 岐阜, Domestic conference
    Oral presentation

  • Three cases of complete hydatidiform mole coexistent with a live twin fetus
    Hikari Yoshizawa, Yasuhiko Ebina, Hitomi Imafuku, Kaho Suzuki, Senn Wakahashi, Yoshiya Miyahara, Masashi Deguchi, Hideto Yamada
    第70回日本産科婦人科学会学術講演会, May 2018, English, 仙台, Domestic conference
    Poster presentation

  • Risk Factors for Deep Venous Thrombosis in Women with Ovarian Cancer
    Tetsuya Kawaguchi, Yasuhiko Ebina, Mihoko Uchiyama, Hitomi Imafuku, Kaho Suzuki, Yoshiya Miyahara, Hideto Yamada
    第70回日本産科婦人科学会学術講演会, May 2018, English, 仙台, Domestic conference
    Poster presentation

  • Pregnancy outcomes subsequent to uterine arterial embolization for severe post-partum hemorrhage
    Hitomi Imafuku, Mayumi Morizane, Tokuro Shirakawa, Kenji Tanimura, Masashi Deguchi, Hideto Yamada
    第70回日本産科婦人科学会学術講演会, May 2018, English, 仙台, Domestic conference
    Poster presentation

  • 治療抵抗性の抗リン脂質抗体症候群合併妊娠に対する大量免疫グロブリン療法
    Deguchi Masashi, Tanimura Kenji, Shinozaki Nanae, Imafuku Hitomi, Maesawa Yoko, Tairaku Shinya, 葉 宜慧, Yamada Hideto
    第131回近畿産科婦人科学会学術集会, Oct. 2014, Japanese, 近畿産婦人科学会, 大阪, Domestic conference
    Oral presentation

  • 子宮頸部円錐切除術施行例の治療成績と妊娠予後
    白川 友香, Imafuku Hitomi, 豊永 絢香, 野村 晃子, 施 裕徳, 田中恵理加, 白川 得朗, 小嶋 伸恵, Suzuki Kaho, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Niiya Kiyoshi, Ebina Yasuhiko, Morita Hiroki, Yamada Hideto
    第131回近畿産科婦人科学会学術集会, Oct. 2014, Japanese, 近畿産婦人科学会, 大阪, Domestic conference
    Oral presentation

  • 腹腔鏡手術中に器具が破損した2症例
    Ikuhashi Yoshiyuki, Matsuoka Shozo, 山崎 友維, 白川 友香, Imafuku Hitomi, 牧原 夏子, Suzuki Kaho, Morizane Mayumi, Ebina Yasuhiko, Yamada Hideto
    第54回日本産科婦人科内視鏡学会学術講演会, Sep. 2014, Japanese, 日本産科婦人科内視鏡学会, 鹿児島, Domestic conference
    Oral presentation

  • 腹腔鏡下子宮全摘術における腟管切断時の工夫
    Matsuoka Shozo, Ikuhashi Yoshiyuki, Imafuku Hitomi, Suzuki Kaho, 小嶋 伸恵, 山崎 友維, Ebina Yasuhiko, Morita Hiroki, Yamada Hideto
    第54回日本産科婦人科内視鏡学会学術講演会, Sep. 2014, Japanese, 日本産科婦人科内視鏡学会, 鹿児島, Domestic conference
    Oral presentation

  • クラミジア直腸炎の1例
    Miyahara Yoshiya, 山崎 友維, Imafuku Hitomi, Ikuhashi Yoshiyuki, Niiya Kiyoshi, Ebina Yasuhiko, Morita Hiroki, Yamada Hideto
    第32回日本クラミジア研究会, Sep. 2014, Japanese, 日本産科婦人科学会, 京都, Domestic conference
    Oral presentation

  • 当院における子宮頸癌に対する根治的放射線治療の現状
    Imafuku Hitomi, Ebina Yasuhiko, Suzuki Kaho, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Niiya Kiyoshi, Morita Hiroki, Yamada Hideto
    平成26年度位育会臨床セミナー, Aug. 2014, Japanese, 位育会, 神戸, Domestic conference
    Oral presentation

  • 術前GnRH療法および術後ジエノゲスト療法を併用した水腎症合併子宮内膜症の2例
    Suzuki Kaho, Ebina Yasuhiko, 山崎 友維, 白川 友香, Imafuku Hitomi, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Niiya Kiyoshi, Morita Hiroki, Yamada Hideto
    25回近畿エンドメトリオージス研究会, Aug. 2014, Japanese, 日本エン鳥オーシス学会, 大阪, Domestic conference
    Oral presentation

  • 婦人科癌術前PET-CTで発見された重複癌症例に関する臨床的検討
    白川 友香, Niiya Kiyoshi, 山崎 友維, Imafuku Hitomi, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Morita Hiroki, Ebina Yasuhiko, Yamada Hideto
    第56回日本婦人科腫瘍学会学術講演会, Jul. 2014, Japanese, 第56回日本婦人科腫瘍学会, 宇都宮, Domestic conference
    Oral presentation

  • 子宮体癌根治術における廓清リンパ節および子宮筋層にリンパ脈管筋腫症細胞を認めた一例
    Morita Hiroki, 山崎 友維, 白川 友香, Tairaku Shinya, Suzuki Kaho, Imafuku Hitomi, Ikuhashi Yoshiyuki, Deguchi Masashi, Miyahara Yoshiya, Niiya Kiyoshi, Ebina Yasuhiko, Kawakami Fumi, Yamada Hideto
    第56回日本婦人科腫瘍学会学術講演会, Jul. 2014, Japanese, 第57回日本婦人科腫瘍学会, 宇都宮, Domestic conference
    Oral presentation

  • 癌性腹膜炎との鑑別を要した結核性腹膜炎の1症例
    山崎 友維, Ebina Yasuhiko, 石原あゆみ, 白川 友香, Imafuku Hitomi, Suzuki Kaho, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Niiya Kiyoshi, Morita Hiroki, Yamada Hideto
    第56回日本婦人科腫瘍学会学術講演会, Jul. 2014, Japanese, 第58回日本婦人科腫瘍学会, 宇都宮, Domestic conference
    Oral presentation

  • 婦人科癌術前PET-CTで発見された重複癌症例に関する臨床的検討
    白川 友香, Niiya Kiyoshi, Imafuku Hitomi, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Morita Hiroki, Ebina Yasuhiko, Yamada Hideto
    第130回近畿産科婦人科学会学術集会, Jun. 2014, Japanese, 近畿産婦人科学会, 大阪, Domestic conference
    Oral presentation

  • 子宮頸部病変におけるHPVタイピングの意義
    上田 萩子, Ebina Yasuhiko, 足立 陽子, 山崎 友維, 白川 友香, Imafuku Hitomi, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Niiya Kiyoshi, Morita Hiroki, Yamada Hideto
    第88回兵庫県産科婦人科学会学術集会, Jun. 2014, Japanese, 日本産科婦人科学会, 神戸, Domestic conference
    Oral presentation

  • 骨盤内から後腹膜腔へ発達した巨大なparasitic myomaの1例
    Niiya Kiyoshi, 長又 哲史, Imafuku Hitomi, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Ebina Yasuhiko, Morita Hiroki
    第130回近畿産科婦人科学会学術集会, Jun. 2014, Japanese, 近畿産婦人科学会, 大阪, Domestic conference
    Oral presentation

  • 癌性腹膜炎との鑑別が困難であった結核性腹膜炎の1例
    石原あゆみ, Ebina Yasuhiko, 足立 陽子, 上田 萩子, 山崎 友維, 白川 友香, Imafuku Hitomi, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Niiya Kiyoshi, Morita Hiroki, Yamada Hideto
    第88回兵庫県産科婦人科学会学術集会, Jun. 2014, Japanese, 日本産科婦人科学会, 神戸, Domestic conference
    Oral presentation

  • クラミジア直腸炎の1例
    Miyahara Yoshiya, 山崎 友維, Imafuku Hitomi, Ikuhashi Yoshiyuki, Niiya Kiyoshi, Ebina Yasuhiko, Morita Hiroki, Yamada Hideto
    第31回日本産婦人科感染症研究会, Jun. 2014, Japanese, 日本産婦人科感染症研究会, 神戸, Domestic conference
    Oral presentation

  • CIN患者におけるHPVタイピング検査の臨床的意義
    Imafuku Hitomi, Ebina Yasuhiko, 山崎 友維, Ikuhashi Yoshiyuki, Niiya Kiyoshi, Miyahara Yoshiya, Morita Hiroki, Yamada Hideto
    第31回日本産婦人科感染症研究会, Jun. 2014, Japanese, 日本産婦人科感染症研究会, 神戸, Domestic conference
    Oral presentation

  • ASC-H症例の臨床経過と細胞診所見に関する検討
    足立 陽子, Ebina Yasuhiko, 上田 萩子, 山崎 友維, 白川 友香, Imafuku Hitomi, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Niiya Kiyoshi, Morita Hiroki, Yamada Hideto
    第88回兵庫県産科婦人科学会学術集会, Jun. 2014, Japanese, 日本産科婦人科学会, 神戸, Domestic conference
    Oral presentation

  • 卵巣奇形腫における悪性転化の術前予測についての検討
    牧原 夏子, Ebina Yasuhiko, 山崎 友維, Imafuku Hitomi, Ikuhashi Yoshiyuki, Matsuoka Shozo, Miyahara Yoshiya, Niiya Kiyoshi, Morita Hiroki, Yamada Hideto
    第66回日本産科婦人科学会学術講演会, Apr. 2014, Japanese, 日本産科婦人科学会, 東京, Domestic conference
    Poster presentation

  • 癒着胎盤における絨毛細胞の上皮間葉変換に関する解析
    白川 得朗, Miyahara Yoshiya, Imafuku Hitomi, 牧原 夏子, Ebina Yasuhiko, Yamada Hideto
    第66回日本産科婦人科学会学術講演会, Apr. 2014, Japanese, 日本産科婦人科学会, 東京, Domestic conference
    Poster presentation

  • 婦人科癌術前PET-CTで発見された重複癌症例に関する臨床的検討
    Niiya Kiyoshi, Ebina Yasuhiko, 西本 昌司, 山崎 友維, Imafuku Hitomi, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Morita Hiroki, Yamada Hideto
    第66回日本産科婦人科学会学術講演会, Apr. 2014, Japanese, 日本産科婦人科学会, 東京, Domestic conference
    Poster presentation

  • 転移性子宮腫瘍の診断に腹水セルブロック法が有用であった2症例
    Ikuhashi Yoshiyuki, Ebina Yasuhiko, 西本 昌司, 山崎 友維, Imafuku Hitomi, Niiya Kiyoshi, Miyahara Yoshiya, Morita Hiroki, Yamada Hideto
    第66回日本産科婦人科学会学術講演会, Apr. 2014, Japanese, 日本産科婦人科学会, 東京, Domestic conference
    Poster presentation

  • ASC-H症例の臨床経過と細胞診所見に関する検討
    Imafuku Hitomi, Ebina Yasuhiko, 西本 昌司, 山崎 友維, Ikuhashi Yoshiyuki, Niiya Kiyoshi, Miyahara Yoshiya, Morita Hiroki, Yamada Hideto
    第66回日本産科婦人科学会学術講演会, Apr. 2014, Japanese, 日本産科婦人科学会, 東京, Domestic conference
    Poster presentation

  • クラミジア直腸炎の1例
    Miyahara Yoshiya, 山崎 友維, Imafuku Hitomi, Ikuhashi Yoshiyuki, Niiya Kiyoshi, Ebina Yasuhiko, Morita Hiroki, Yamada Hideto
    第19回兵庫県性感染症（STI）研究会, Mar. 2014, Japanese, 神戸, Domestic conference
    Oral presentation

  • 術前GnRH療法および術後ジエノゲスト療法を併用した水腎症合併重症子宮内膜症の2例
    Ebina Yasuhiko, 上田 萩子, 西本 昌司, 山崎 友維, Imafuku Hitomi, Ikuhashi Yoshiyuki, Miyahara Yoshiya, Niiya Kiyoshi, Morita Hiroki, Yamada Hideto
    第35回日本エンドメトリオーシス学会, Jan. 2014, Japanese, 日本エンドリオーシス学会, 鹿児島, Domestic conference
    Oral presentation

■ Research Themes
  • 末梢血・脱落膜免疫細胞プロファイル網羅的解析による不育症関連免疫異常の病態解析
    出口 雅士, 益子 尚久, 今福 仁美, 宮西 正憲, 谷村 憲司, 寺井 義人
    日本学術振興会, 科学研究費助成事業, 基盤研究(C), 神戸大学, 01 Apr. 2025 - 31 Mar. 2028

  • Elucidation of the mechanism of neoself antibody-induced recurrent pregnancy loss using model mice and development of the treatment methods
    谷村 憲司, 出口 雅士, 今福 仁美, 寺井 義人
    Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Kobe University, 01 Apr. 2024 - 31 Mar. 2027

  • 癒着胎盤の発生に関わるmiRNAの同定および癒着胎盤分娩前評価法の確立
    今福 仁美
    日本学術振興会, 科学研究費助成事業, 若手研究, 神戸大学, 01 Apr. 2022 - 31 Mar. 2025

TOP